A critical requirement for the future of outstanding health care in the United States is the training of physician-scientists who will investigate fundamental basic science questions which ultimately relate to clinical problems. The mission of the M.D./Ph.D. program of Mayo Medical and Graduate Schools is to train a small number of gifted students in the methods, tools and disciplines of the laboratory basic scientist, while also helping them develop skills for relieving human suffering. The faculty for the Mayo MSTP will include 57 of the most highly productive, well-funded research scientists at the Mayo Clinic with demonstrated abilities for mentoring young scientists. The seamless integration of the M.D./Ph.D. program between Mayo Medical School and Mayo Graduate School parallels the complete integration of basic research and clinical investigation at Mayo. These collaborations among Ph.D. scientists and physician scientists model the future careers for M.D./Ph.D. students. The Mayo M.D./Ph.D. program enrolls approximately 6 new students each year in a medical school class o 42. M.D./Ph.D. students are selected from an annual applicant pool of about 150 of the most talented future physician scientists in the country. During their M.D./Ph.D. training they mature into highly productive basic scientists. The integrated basic science core curriculum and programmatic approach to research allows flexible access to an outstanding selection of research faculty as mentors for Mayo MSTP students. Although this is a relatively young program, 39 students have graduated and 36 are currently enrolled. Graduates are continuing on toward successful careers and continuing to make significant scientific contributions. As an NIGMS-designated MSTP the Mayo program will be able to further improve and increase its impact on the training of much-needed physician scientists prepared to apply the explosive growth in biomedical information to important clinical problems.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Shapiro, Bert I
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Wilton, Katelynn M; Billadeau, Daniel D (2018) VASP Regulates NK Cell Lytic Granule Convergence. J Immunol 201:2899-2909
Naylor, Ryan M; Wohl, Anton; Raghunathan, Aditya et al. (2018) Novel suprasellar location of desmoplastic infantile astrocytoma and ganglioglioma: a single institution's experience. J Neurosurg Pediatr 22:397-403
Jo, Hang Joon; McCairn, Kevin W; Gibson, William S et al. (2018) Global network modulation during thalamic stimulation for Tourette syndrome. Neuroimage Clin 18:502-509
Moyer, Ann M; de Andrade, Mariza; Faubion, Stephanie S et al. (2018) SLCO1B1 genetic variation and hormone therapy in menopausal women. Menopause 25:877-882
Li, Lei; Liu, Tongzheng; Li, Yunhui et al. (2018) The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization. Oncogene 37:2422-2431
Paradise, Brooke D; Barham, Whitney; Fernandez-Zapico, Martín E (2018) Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes? Cancers (Basel) 10:
Edwards, Christine A; Rusheen, Aaron E; Oh, Yoonbae et al. (2018) A novel re-attachable stereotactic frame for MRI-guided neuronavigation and its validation in a large animal and human cadaver model. J Neural Eng 15:066003
Livia, Christopher; Sugrue, Alan; Witt, Tyra et al. (2018) Elimination of Purkinje Fibers by Electroporation Reduces Ventricular Fibrillation Vulnerability. J Am Heart Assoc 7:e009070
Smestad, John; Hamidi, Oksana; Wang, Lin et al. (2018) Characterization and metabolic synthetic lethal testing in a new model of SDH-loss familial pheochromocytoma and paraganglioma. Oncotarget 9:6109-6127
Joseph, Josiane; Cho, Dong Seong; Doles, Jason D (2018) Metabolomic Analyses Reveal Extensive Progenitor Cell Deficiencies in a Mouse Model of Duchenne Muscular Dystrophy. Metabolites 8:

Showing the most recent 10 out of 112 publications